Digital Direct-to-Consumer Advertising: A Perfect Storm of Rapid Evolution and Stagnant Regulation; Comment on 'Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters'

Int J Health Policy Manag. 5(4):271-274, 2016, DOI: 10.15171/ijhpm.2016.11

4 Pages Posted: 5 Mar 2016

See all articles by Tim Mackey

Tim Mackey

University of California, San Diego (UCSD) - Department of Anesthesiology

Date Written: March 1, 2016

Abstract

The adoption and use of digital forms of direct-to-consumer advertising (also known as “eDTCA”) is on the rise. At the same time, the universe of eDTCA is expanding, as technology on Internet-based platforms continues to evolve, from static websites, to social media, and nearly ubiquitous use of mobile devices. However, little is known about how this unique form of pharmaceutical marketing impacts consumer behavior, public health, and overall healthcare utilization. The study by Kim analyzing US Food and Drug Administration (FDA) notices of violations (NOVs) and warning letters regarding online promotional activities takes us in the right direction, but study results raise as many questions as it does answers. Chief among these are unanswered concerns about the unique regulatory challenges posed by the “disruptive” qualities of eDTCA, and whether regulators have sufficient resources and oversight powers to proactively address potential violations. Further, the globalization of eDTCA via borderless Internet-based technologies raises larger concerns about the potential global impact of this form of health marketing unique to only the United States and New Zealand. Collectively, these challenges make it unlikely that regulatory science will be able to keep apace with the continued rapid evolution of eDTCA unless more creative policy solutions are explored.

Keywords: Direct-to-Consumer Advertising (DTCA); Social Media; Pharmaceutical Marketing; Health Communication; Regulatory Science; Food and Drug Administration (FDA)

Suggested Citation

Mackey, Tim, Digital Direct-to-Consumer Advertising: A Perfect Storm of Rapid Evolution and Stagnant Regulation; Comment on 'Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters' (March 1, 2016). Int J Health Policy Manag. 5(4):271-274, 2016, DOI: 10.15171/ijhpm.2016.11, Available at SSRN: https://ssrn.com/abstract=2741210

Tim Mackey (Contact Author)

University of California, San Diego (UCSD) - Department of Anesthesiology ( email )

School of Medicine
La Jolla, CA 92093
United States

Do you have negative results from your research you’d like to share?

Paper statistics

Downloads
37
Abstract Views
478
PlumX Metrics